Feedback
European Shorting
My Portfolios
Browse Gurus
Print
Email
Kensey Nash Corporation designs develops manufactures and processesproprietary biomaterials products for the orthopedics cardiologydrug/biologics delivery and wound care markets. The company also is involved with cardiovascular medical technology specifically arterial revascularization and puncture closure devices. The company intends to leverage its proprietary knowledge and expertise to develop new products and technologies and to explore additional applications for its products. Kensey Nash Corp. has a market cap of $321.6 million; its shares were traded at around $28.92 with a P/E ratio of 17 and P/S ratio of 3.9.
Recent Trades of Kensey Nash Corp. by Directors and Officers:
- Sell: VP New Technologies John E Nash sold 1,000 shares of KNSY stock on 10/05/2009 at the average price of $28.32; the price of the stock has increased by 2.12% since.
- Sell: Director Walter R Jr Maupay sold 4,500 shares of KNSY stock on 10/01/2009 at the average price of $28.33; the price of the stock has increased by 2.08% since.
- Sell: VP of Operations James T Rauth sold 3,733 shares of KNSY stock on 09/25/2009 at the average price of $28; the price of the stock has increased by 3.29% since.
- Sell: VP of Operations James T Rauth sold 3,733 more shares of KNSY stock on 09/25/2009 at the average price of $28; the price of the stock has increased by 3.29% since.
- Sell: VP of Operations James T Rauth sold 300 more shares of KNSY stock on 09/21/2009 at the average price of $29; the price of the stock has decreased by 0.28% since.
Subscribe RSS
RSS